DUBLIN, Calif. & JENA, Germany--(BUSINESS WIRE)--Carl Zeiss Meditec announced its intention to initiate a US clinical trial of the ReLEx smile procedure for the correction of myopia, having received conditional approval for the trial from the US Food and Drug Administration (FDA).
